CN113288998A - Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme - Google Patents

Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme Download PDF

Info

Publication number
CN113288998A
CN113288998A CN202010110271.8A CN202010110271A CN113288998A CN 113288998 A CN113288998 A CN 113288998A CN 202010110271 A CN202010110271 A CN 202010110271A CN 113288998 A CN113288998 A CN 113288998A
Authority
CN
China
Prior art keywords
parts
weight
blood
blood sugar
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010110271.8A
Other languages
Chinese (zh)
Inventor
杜善喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fangchenggang Jirentang Tcm Clinic
Original Assignee
Fangchenggang Jirentang Tcm Clinic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fangchenggang Jirentang Tcm Clinic filed Critical Fangchenggang Jirentang Tcm Clinic
Priority to CN202010110271.8A priority Critical patent/CN113288998A/en
Publication of CN113288998A publication Critical patent/CN113288998A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/424—Gynostemma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for stabilizing blood sugar diseases and a preparation scheme, wherein the traditional Chinese medicine formula is prepared from the following raw materials in parts by weight: 8-10 parts of angelica sinensis, 6-8 parts of codonopsis pilosula, 3-5 parts of safflower, 8-10 parts of kudzu root, 8-10 parts of red peony root, 7-12 parts of pseudo-ginseng, 6-8 parts of pawpaw, 7-12 parts of uncaria, 8-12 parts of fructus choerospondiatis, 2-3 parts of leech and 8-10 parts of gynostemma pentaphylla; 20-25 parts of soybean peptide; 30-50 parts of pig blood or deer blood; the invention can realize the stable control of blood sugar diseases; in addition, the health-care pillow can improve the imbalance of qi and blood supply and demand, the dysfunction of spleen deficiency and transportation and the deficiency of kidney essence, and finally has the effects of health care and health recovery on human bodies, and improves the sleep and life quality. The invention has the following contraindications: spicy food, various wines and products thereof; the pregnant women are fasted.

Description

Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine formula for stabilizing blood sugar diseases and a preparation scheme.
Background
A normal fasting blood glucose level is 6.1mmol/L or less, a normal postprandial blood glucose level of two hours is 7.8mmol/L or less, and a level higher than this range is called hyperglycemia. Under normal conditions, a human body can ensure the balance of the source and the route of blood sugar through two major regulating systems of hormone regulation and nerve regulation, so that the blood sugar is maintained at a certain level. However, under the combined action of genetic factors and environmental factors, such as diet and obesity with unreasonable family history of diabetes, the two major regulatory functions are disordered, and the blood sugar level is increased.
With the improvement of life quality, people drink irregular diet and lack of exercise to cause the rise of blood sugar, western medicine can only inhibit or maintain blood sugar diseases, such as hyperglycemia, and take chemical synthetic medicines which have great side effects, so that patients are often accompanied with other complications, and finally no medicine can be saved.
Disclosure of Invention
In view of the above, the present invention aims to provide a traditional Chinese medicine prescription for stabilizing blood sugar diseases and a preparation method thereof, and the traditional Chinese medicine prescription provided by the present invention can realize stable control of blood sugar diseases and greatly reduce incidence rate of diseases.
In order to solve the problems, the invention provides a traditional Chinese medicine formula for stabilizing blood sugar diseases, which is prepared from the following raw materials in parts by weight: 8-10 parts of angelica sinensis, 6-8 parts of codonopsis pilosula, 3-5 parts of safflower, 8-10 parts of kudzu root, 8-10 parts of red peony root, 7-12 parts of pseudo-ginseng, 6-8 parts of pawpaw, 7-12 parts of uncaria, 8-12 parts of fructus choerospondiatis, 2-3 parts of leech and 8-10 parts of gynostemma pentaphylla; 20-25 parts of soybean peptide; 30-50 parts of pig blood or deer blood.
Preferably, the traditional Chinese medicine formula is prepared from the following raw materials in parts by weight: 8 parts of angelica sinensis, 6 parts of codonopsis pilosula, 3 parts of safflower, 8 parts of kudzu root, 8 parts of red peony root, 7 parts of pseudo-ginseng, 6 parts of pawpaw, 7 parts of uncaria, 8 parts of fructus choerospondiatis, 2 parts of leech and 8 parts of gynostemma pentaphylla; 20 parts of soybean peptide; 30 parts of pig blood.
Preferably, the traditional Chinese medicine formula is prepared from the following raw materials in parts by weight: 10 parts of angelica sinensis, 8 parts of codonopsis pilosula, 5 parts of safflower, 10 parts of kudzu root, 10 parts of red peony root, 12 parts of pseudo-ginseng, 8 parts of pawpaw, 12 parts of uncaria, 12 parts of fructus choerospondiatis, 3 parts of leech and 10 parts of gynostemma pentaphylla; 25 parts of soybean peptide; 50 parts of pig blood.
Preferably, the traditional Chinese medicine formula is prepared from the following raw materials in parts by weight: 9 parts of angelica sinensis, 7 parts of codonopsis pilosula, 4 parts of safflower, 9 parts of kudzu root, 9 parts of red peony root, 10 parts of pseudo-ginseng, 7 parts of pawpaw, 10 parts of uncaria, 10 parts of fructus choerospondiatis, 3 parts of leech and 9 parts of gynostemma pentaphylla; 23 parts of soybean peptide; 40 parts of deer blood.
In another aspect of the present invention, a method for preparing a Chinese medicinal formulation for stabilizing blood sugar diseases is provided, which comprises the following steps:
a) soaking 8-10 parts by weight of radix puerariae and 7-12 parts by weight of uncaria rhynchophylla in old vinegar for 24 hours, taking out the radix puerariae and the uncaria rhynchophylla, and airing for later use;
b) b, crushing the kudzu roots and the uncaria which are dried in the step a by a crusher to obtain 70-90 mesh powder particles for later use;
c) mixing the kudzu root and the uncaria processed in the step b with 8-10 parts by weight of Chinese angelica, 6-8 parts by weight of dangshen, 3-5 parts by weight of safflower, 8-10 parts by weight of red paeony root, 7-12 parts by weight of pseudo-ginseng, 6-8 parts by weight of pawpaw, 8-12 parts by weight of fructus choerospondiatis, 2-3 parts by weight of leech, 8-10 parts by weight of gynostemma pentaphylla and 20-25 parts by weight of soybean peptide to obtain a Chinese medicinal mixture;
d) and c, adding 30-50 parts by weight of pig blood into the traditional Chinese medicine mixture obtained in the step c, steaming the mixture in a steam box for 1 hour, taking out the mixture, cooling the mixture to normal temperature, drying the mixture, and crushing the dried mixture by a crusher to 80-100 meshes to obtain the finished product of the traditional Chinese medicine prescription.
Further, in the step d, the 30-50 parts by weight of the pig blood can be replaced by the deer blood, and the proportion of the parts by weight of the pig blood is unchanged after the pig blood is replaced by the deer blood.
Further, the finished product of the traditional Chinese medicine formula can be prepared into tablets and capsules.
The technical scheme of the invention has the following beneficial technical effects: the stable control of blood sugar diseases can be realized; in addition, the health-care pillow can improve the imbalance of qi and blood supply and demand, the dysfunction of spleen deficiency and transportation and the deficiency of kidney essence, and finally has the effects of health care and health recovery on human bodies, and improves the sleep and life quality.
The invention has the following contraindications: spicy food, various wines and products thereof; the pregnant women are fasted.
Drawings
FIG. 1 is a flow chart of the preparation method of a Chinese medicinal prescription for stabilizing blood sugar diseases according to the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the accompanying drawings in conjunction with the following detailed description. It should be understood that the description is intended to be exemplary only, and is not intended to limit the scope of the present invention. Moreover, in the following description, descriptions of well-known structures and techniques are omitted so as to not unnecessarily obscure the concepts of the present invention.
The invention provides a traditional Chinese medicine prescription for stabilizing blood sugar diseases, which is prepared from the following raw materials in parts by weight: 8-10 parts of angelica sinensis, 6-8 parts of codonopsis pilosula, 3-5 parts of safflower, 8-10 parts of kudzu root, 8-10 parts of red peony root, 7-12 parts of pseudo-ginseng, 6-8 parts of pawpaw, 7-12 parts of uncaria, 8-12 parts of fructus choerospondiatis, 2-3 parts of leech and 8-10 parts of gynostemma pentaphylla; 20-25 parts of soybean peptide; 30-50 parts of pig blood or deer blood.
The traditional Chinese medicine prescription provided by the invention is prepared from raw materials, wherein the raw materials comprise angelica sinensis, codonopsis pilosula, safflower, radix puerariae, radix paeoniae rubra, pseudo-ginseng, pawpaw, uncaria, fructus choerospondiatis, leech and gynostemma pentaphylla; a soybean peptide; pig blood or deer blood.
In a specific embodiment of the invention, the traditional Chinese medicine formula is prepared from the following raw materials in parts by weight: 9 parts of angelica sinensis, 7 parts of codonopsis pilosula, 4 parts of safflower, 9 parts of kudzu root, 9 parts of red peony root, 10 parts of pseudo-ginseng, 7 parts of pawpaw, 10 parts of uncaria, 10 parts of fructus choerospondiatis, 3 parts of leech and 9 parts of gynostemma pentaphylla; 23 parts of soybean peptide; 40 parts of deer blood.
Referring to fig. 1 and fig. 1, a method for preparing a Chinese medicinal formulation for stabilizing blood sugar diseases comprises the following steps:
a) soaking 9 parts by weight of radix puerariae and 10 parts by weight of uncaria rhynchophylla in old vinegar for 24 hours, taking out the radix puerariae and the uncaria rhynchophylla, and airing for later use;
b) b, crushing the kudzu roots and the uncaria which are dried in the step a by a crusher to 80-mesh powder particles for later use;
c) b, mixing the kudzu root and the uncaria processed in the step b with 9 parts by weight of Chinese angelica, 7 parts by weight of codonopsis pilosula, 4 parts by weight of safflower, 9 parts by weight of red paeony root, 10 parts by weight of pseudo-ginseng, 7 parts by weight of pawpaw, 10 parts by weight of fructus choerospondiatis, 3 parts by weight of leech, 9 parts by weight of gynostemma pentaphylla and 23 parts by weight of soybean peptide to obtain a Chinese medicinal mixture;
d) and c, adding 40 parts by weight of pig blood into the traditional Chinese medicine mixture obtained in the step c, steaming the mixture in a steam box for 1 hour, taking out the mixture, cooling the mixture to the normal temperature, drying the mixture, and crushing the dried mixture to 100 meshes by using a crusher to obtain a finished product of the traditional Chinese medicine formula.
The traditional Chinese medicine prescription is added with pharmaceutically conventional auxiliary materials to prepare clinically acceptable capsules and tablets, and is convenient for patients to take.
The angelica has sweet and pungent taste, warm property and slight bitter taste, enters liver, heart and spleen channels, and has the effects of tonifying qi, enriching blood, tonifying deficiency, activating blood, regulating menstruation and relieving pain. In the above embodiment provided by the present invention, the content of the angelica sinensis in the raw materials is 9 parts by weight; in other embodiments provided by the present invention, the content of the angelica in the raw material is 10 parts by weight or 8 parts by weight.
In the invention, the codonopsis pilosula can expand peripheral blood vessels to reduce blood pressure and inhibit the pressure increasing effect of epinephrine. In the above embodiment provided by the present invention, the content of the codonopsis pilosula in the raw materials is 7 parts by weight; in other embodiments provided by the present invention, the content of the codonopsis pilosula in the raw material is 6 parts by weight or 8 parts by weight.
In the invention, the safflower has the effects of promoting blood circulation, dredging channels, dissipating blood stasis and relieving pain, and is beneficial to treating amenorrhea, dysmenorrheal, lochiorrhea, chest stuffiness and pains, stasis and abdominal pain, stabbing pain in chest and hypochondrium, traumatic injury and sore and ulcer swelling and pain. Has effects of promoting blood circulation, removing blood stasis, eliminating dampness, and relieving swelling. In the above examples provided by the present invention, the content of the safflower in the raw material is 4 parts by weight; in other examples provided by the present invention, the content of the safflower in the raw material is 3 parts by weight or 5 parts by weight.
In the invention, the kudzuvine root has the functions of relieving muscles and fever, promoting eruption, promoting the production of body fluid to quench thirst, and invigorating yang to arrest diarrhea. It is commonly indicated for exterior syndrome with fever, stiffness and pain of neck and back, measles without adequate eruption, thirst due to fever, diabetes due to yin deficiency, dysentery due to heat-purging and diarrhea due to spleen deficiency. In the above embodiment provided by the present invention, the content of the pueraria root in the raw materials is 9 parts by weight; in other embodiments provided by the present invention, the content of the pueraria lobata in the raw material is 10 parts by weight or 8 parts by weight.
In the invention, the red peony root has the effects of clearing heat and cooling blood, and activating blood and removing stasis. In the above embodiment provided by the present invention, the content of the red peony root in the raw material is 9 parts by weight; in other embodiments provided by the present invention, the content of the red peony root in the raw material is 10 parts by weight or 8 parts by weight.
In the invention, the pseudo-ginseng is sweet, slightly bitter and warm in taste, enters liver and stomach channels, and has the effects of reducing blood pressure, reducing cholesterol, dilating blood vessels, improving microcirculation, increasing blood flow, and preventing and treating heart and brain tissue ischemia and hypoxia. In the above embodiment provided by the present invention, the content of the notoginseng in the raw materials is 10 parts by weight; in other embodiments provided by the present invention, the content of the notoginseng in the raw material is 12 parts by weight or 7 parts by weight.
In the invention, the pawpaw has the effects of treating stomachache, dysentery, constipation and anemogenous arthritis, and in the embodiment provided by the invention, the content of the pawpaw in the raw materials is 7 parts by weight; in other embodiments provided by the present invention, the content of the papaya in the raw material is 8 parts by weight or 6 parts by weight.
In the invention, the uncaria has the effects of clearing heat, calming liver, calming wind and arresting convulsion and also has the effect of reducing blood pressure. In the embodiment provided by the invention, the content of the uncaria in the raw materials is 10 parts by weight; in other embodiments provided by the present invention, the content of the uncaria in the raw material is 12 parts by weight or 7 parts by weight.
In the invention, the fructus choerospondiatis has the effects of promoting qi and blood circulation, nourishing heart, soothing nerves, resisting myocardial ischemia, protecting cardiac function and the like. In the above embodiment provided by the present invention, the content of the fructus choerospondiatis in the raw material is 10 parts by weight; in other embodiments provided by the present invention, the content of the fructus choerospondiatis in the raw material is 12 parts by weight or 7 parts by weight.
In the invention, the leech is salty, bitter and mild in taste and has small toxicity, and has the effects of breaking blood, removing stasis, dredging collaterals, resisting coagulation, reducing blood fat, resisting cancer and inhibiting cancers. In the above embodiment provided by the present invention, the content of the leech in the raw material is 2 parts by weight; in other embodiments provided by the present invention, the leech is contained in the raw material in an amount of 3 parts by weight.
In the invention, the gynostemma pentaphylla has the effects of reducing blood fat, regulating blood pressure, preventing and treating thrombus, preventing and treating cardiovascular diseases, regulating blood sugar, promoting sleep, delaying aging, preventing and resisting cancers, improving immunity and regulating physiological functions of a human body. In the above embodiment provided by the present invention, the content of the gynostemma pentaphyllum in the raw material is 9 parts by weight; in other embodiments provided by the present invention, the content of the gynostemma pentaphyllum in the raw material is 10 parts by weight or 8 parts by weight.
In the invention, the soybean peptide has slightly bitter taste, contains bioactive peptides such as arginine, glutamic acid and the like, and has the effects of multiple physiological activities and immunity improvement. In the above examples provided by the present invention, the content of the soybean peptide in the raw material was 23 parts by weight; in other examples provided herein, the soybean peptides are present in the starting materials in an amount of 25 parts by weight and 20 parts by weight.
In the invention, the pig blood has sweet and salty taste, mild nature, heart and liver channels, and has the effects of heart deficiency, insomnia, palpitation, spontaneous perspiration, malnutrition to heart muscle and enhancement of myocardial contractility. In the above embodiment provided by the present invention, the content of the pig blood in the raw material is 40 parts by weight; in other embodiments provided by the present invention, the content of the pig blood in the raw material is 30 parts by weight or 50 parts by weight.
In the invention, the deer blood has the effects of nourishing blood and replenishing vital essence, promoting blood circulation and removing blood stasis, and reducing swelling and curing injury. In the above embodiment provided by the present invention, the deer blood content in the raw material is 40 parts by weight; in other embodiments provided by the present invention, the deer blood content in the raw material is 30 parts by weight or 50 parts by weight.
The Chinese medicinal formula prepared by the invention is added with pharmaceutically conventional auxiliary materials to prepare clinically acceptable tablets for patients to take, and the application of the invention is as follows.
Clinical application
1. And (3) clinical observation:
100 hypertensive patients were randomly selected as clinical observations, of which 56 men, 44 women, 40-70 years old, and 55 years old were the average age, and all had no other serious diseases.
2. The treatment method comprises the following steps:
is orally taken 1 time a day, and 7-10 g is taken 1 time.
3. The evaluation standard of curative effect is as follows:
the method has the following advantages: the constitution is strengthened, the blood sugar is obviously reduced and tends to be stable.
And (4) invalidation: the physical signs of clinical symptoms are not improved, and the blood sugar content is not obviously changed.
4. The treatment results are as follows: 95 cases are effective, 5 cases are ineffective, the total effective rate is 95%, and all patients have no obvious toxic or side effect.
Patient cases:
the female is relaxed at 63 years, and the blood sugar content is obviously reduced after taking the traditional Chinese medicine formula for 30 days, the blood sugar content is reduced to 8mmol/L after 50 days, and the blood sugar is still stable and does not rebound after the traditional Chinese medicine formula is stopped for one month.
Wu, male, 66 years old, retires, and after taking the traditional Chinese medicine preparation of the invention for 30 days, the blood sugar content is obviously reduced, after 50 days, the blood sugar content is reduced to 8.1mmol/L, and after one month of stopping taking, the blood sugar is still stable and does not rebound.
Wangzhi, male, 70 years old, retired, after taking the traditional Chinese medicine preparation of the invention for 40 days, the blood sugar content is obviously reduced, after 60 days, the blood sugar content is reduced to 8.12mmol/L, and after one month of stopping taking, the blood sugar is still stable and does not rebound.
After the Liu female is aged 50 years old and retirees, the blood sugar content is obviously reduced after the Liu female takes the traditional Chinese medicine formula for 20 days, the blood sugar content is reduced to 7.5mmol/L after 40 days, and the blood sugar is still stable and does not rebound after the Liu female stops taking the traditional Chinese medicine formula for one month.
Tang Dynasty, male, 65 years old, retired workers, 2015, 10 months, due to polydipsia, diuresis, polyphagia to local hospital examination, measured blood sugar, blood sugar 15mmol/L, required to take oral insulinotropic agent every day. After taking the tablets prepared by the traditional Chinese medicine prescription in the embodiment of the invention for one treatment course (10 days), the blood sugar content is obviously reduced to 13mmol/L, after taking the tablets for three treatment courses, the blood sugar content is reduced to 8mmol/L, and the blood sugar is still stable and does not rebound after stopping taking the tablets for one month.
Wangzhi, female, 60 years old, retired worker, suddenly developed coma in 2013, examined by hospital, had blood sugar of 17mmol/L and needed to take oral insulinotropic agent every day. After taking the tablets prepared by the traditional Chinese medicine prescription in the embodiment of the invention for one treatment course (10 days), the blood sugar content is obviously reduced to 15mmol/L, after taking three treatment courses, the blood sugar content is reduced to 12mmol/L, after taking six treatment courses, the blood sugar content is reduced to 10mmol/L, and after taking for one month, the blood sugar is still stable and does not rebound.
The financial accounting of a Dong-a woman and a 55-year-old iron and steel enterprise diagnoses that the blood sugar content is higher by 9mmol/L through diagnosis of a plurality of hospitals, the diagnosis has no obvious improvement for a plurality of years, the blood sugar content is obviously reduced to 8mmol/L after taking the tablets prepared by the traditional Chinese medicine prescription in the embodiment of the invention for one treatment course (10 days), the blood sugar content is reduced to 7.1mmol/L after taking three treatment courses, the blood sugar content is reduced to 6.5mmol/L after taking six treatment courses, and the blood sugar is still stable and does not rebound after stopping taking for one year.
The blood sugar content of a certain von, male, 50 years old and farm retired cadres is always swollen with eyes and blurred vision, the blood sugar content is detected to be 11mmol/L by a hospital, after taking the tablets prepared by the traditional Chinese medicine preparation in the embodiment of the invention for one treatment course (10 days), the blood sugar content is obviously reduced to 10.2mmol/L, after taking three treatment courses, the blood sugar content is reduced to 8.1mmol/L, after taking six treatment courses, the blood sugar content is reduced to 7.0mmol/L, and after stopping taking for one year, the blood sugar is still stable and does not rebound.
The retired workers of a 45-year-old large enterprise of Harbin, Wangzhi, have hyperglycemia for years, the blood sugar content is 11.3mmol/L, after taking the tablets prepared by the traditional Chinese medicine formula in the embodiment of the invention for one treatment course (10 days), the blood sugar content is obviously reduced to 10.2mmol/L, after taking three treatment courses, the blood sugar content is reduced to 8.3mmol/L, after taking six treatment courses, the blood sugar content is reduced to 7.2mmol/L, and after stopping taking for one year, the blood sugar is still stable and does not rebound.
In conclusion, the traditional Chinese medicine prescription for stabilizing the blood sugar disease provided by the invention is prepared from the following raw materials in parts by weight: chinese angelica, codonopsis pilosula, safflower, kudzu root, red paeony root, pseudo-ginseng, pawpaw, uncaria, fructus choerospondiatis, leech and gynostemma pentaphylla; a soybean peptide; the pig blood or the deer blood is taken once a day, 7-10 g is taken once, and 10 days are a treatment course until the blood sugar is stable.
The invention has the characteristics of convenient action, good curative effect, quick response and no toxic or side effect.
It is to be understood that the above-described embodiments of the present invention are merely illustrative of or explaining the principles of the invention and are not to be construed as limiting the invention. Therefore, any modification, equivalent replacement, improvement and the like made without departing from the spirit and scope of the present invention should be included in the protection scope of the present invention. Further, it is intended that the appended claims cover all such variations and modifications as fall within the scope and boundaries of the appended claims or the equivalents of such scope and boundaries.

Claims (7)

1. A traditional Chinese medicine prescription for stabilizing blood sugar diseases is characterized by being prepared from the following raw materials in parts by weight: 8-10 parts of angelica sinensis, 6-8 parts of codonopsis pilosula, 3-5 parts of safflower, 8-10 parts of kudzu root, 8-10 parts of red peony root, 7-12 parts of pseudo-ginseng, 6-8 parts of pawpaw, 7-12 parts of uncaria, 8-12 parts of fructus choerospondiatis, 2-3 parts of leech and 8-10 parts of gynostemma pentaphylla; 20-25 parts of soybean peptide; 30-50 parts of pig blood or deer blood.
2. The traditional Chinese medicine formula for stabilizing blood sugar diseases according to claim 1, which is prepared from the following raw materials in parts by weight: 8 parts of angelica sinensis, 6 parts of codonopsis pilosula, 3 parts of safflower, 8 parts of kudzu root, 8 parts of red peony root, 7 parts of pseudo-ginseng, 6 parts of pawpaw, 7 parts of uncaria, 8 parts of fructus choerospondiatis, 2 parts of leech and 8 parts of gynostemma pentaphylla; 20 parts of soybean peptide; 30 parts of pig blood.
3. The traditional Chinese medicine formula for stabilizing blood sugar diseases according to claim 1, which is prepared from the following raw materials in parts by weight: 10 parts of angelica sinensis, 8 parts of codonopsis pilosula, 5 parts of safflower, 10 parts of kudzu root, 10 parts of red peony root, 12 parts of pseudo-ginseng, 8 parts of pawpaw, 12 parts of uncaria, 12 parts of fructus choerospondiatis, 3 parts of leech and 10 parts of gynostemma pentaphylla; 25 parts of soybean peptide; 50 parts of pig blood.
4. The traditional Chinese medicine formula for stabilizing blood sugar diseases according to claim 1, which is prepared from the following raw materials in parts by weight: 9 parts of angelica sinensis, 7 parts of codonopsis pilosula, 4 parts of safflower, 9 parts of kudzu root, 9 parts of red peony root, 10 parts of pseudo-ginseng, 7 parts of pawpaw, 10 parts of uncaria, 10 parts of fructus choerospondiatis, 3 parts of leech and 9 parts of gynostemma pentaphylla; 23 parts of soybean peptide; 40 parts of deer blood.
5. A process for the preparation of a formulation of a Chinese medicinal composition for the stabilization of blood glucose disorders according to any one of claims 1 to 4, comprising the steps of:
a) soaking 8-10 parts by weight of radix puerariae and 7-12 parts by weight of uncaria rhynchophylla in old vinegar for 24 hours, taking out the radix puerariae and the uncaria rhynchophylla, and airing for later use;
b) b, crushing the kudzu roots and the uncaria which are dried in the step a by a crusher to obtain 70-90 mesh powder particles for later use;
c) mixing the kudzu root and the uncaria processed in the step b with 8-10 parts by weight of Chinese angelica, 6-8 parts by weight of dangshen, 3-5 parts by weight of safflower, 8-10 parts by weight of red paeony root, 7-12 parts by weight of pseudo-ginseng, 6-8 parts by weight of pawpaw, 8-12 parts by weight of fructus choerospondiatis, 2-3 parts by weight of leech, 8-10 parts by weight of gynostemma pentaphylla and 20-25 parts by weight of soybean peptide to obtain a Chinese medicinal mixture;
d) and c, adding 30-50 parts by weight of pig blood into the traditional Chinese medicine mixture obtained in the step c, steaming the mixture in a steam box for 1 hour, taking out the mixture, cooling the mixture to normal temperature, drying the mixture, and crushing the dried mixture by a crusher to 80-100 meshes to obtain the finished product of the traditional Chinese medicine prescription.
6. The preparation method of claim 5, wherein in step d, the 30-50 parts by weight of pig blood is replaced by deer blood, and the proportion of the pig blood to the deer blood is unchanged.
7. The preparation method of a Chinese medicinal formula for stabilizing blood sugar diseases according to claim 5, wherein the finished Chinese medicinal formula can be prepared into tablets and capsules.
CN202010110271.8A 2020-02-21 2020-02-21 Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme Pending CN113288998A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010110271.8A CN113288998A (en) 2020-02-21 2020-02-21 Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010110271.8A CN113288998A (en) 2020-02-21 2020-02-21 Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme

Publications (1)

Publication Number Publication Date
CN113288998A true CN113288998A (en) 2021-08-24

Family

ID=77317680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010110271.8A Pending CN113288998A (en) 2020-02-21 2020-02-21 Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme

Country Status (1)

Country Link
CN (1) CN113288998A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708934A (en) * 2016-04-27 2016-06-29 姜国辉 Composition capable of stabilizing blood sugar and reducing blood sugar and preparation process thereof
WO2018040008A1 (en) * 2016-08-31 2018-03-08 广州市利士诺丹生物科技有限公司 Biological traditional chinese medicine for oral administration for treating diabetes mellitus and preparation method therefor
CN108743885A (en) * 2018-08-31 2018-11-06 阴永辉 A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications
CN108853433A (en) * 2018-08-31 2018-11-23 阴永辉 A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708934A (en) * 2016-04-27 2016-06-29 姜国辉 Composition capable of stabilizing blood sugar and reducing blood sugar and preparation process thereof
WO2018040008A1 (en) * 2016-08-31 2018-03-08 广州市利士诺丹生物科技有限公司 Biological traditional chinese medicine for oral administration for treating diabetes mellitus and preparation method therefor
CN108743885A (en) * 2018-08-31 2018-11-06 阴永辉 A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications
CN108853433A (en) * 2018-08-31 2018-11-23 阴永辉 A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
潘道东等: "《功能性食品添加剂》", 中国轻工业出版社, pages: 281 - 282 *

Similar Documents

Publication Publication Date Title
CN102283999B (en) Traditional Chinese medicine preparation for treating insomnia
CN102824503A (en) Concentrated pill for treating atrophic gastritis and strengthening stomach and preparation method thereof
CN101214319B (en) Chinese medicine health care products capable of regulating blood fat and preparation thereof
CN111437317A (en) A Chinese medicinal composition with immunity enhancing effect
CN102696804A (en) Weight-loosing and bodybuilding traditional Chinese medicine tea
CN100515486C (en) Medicine for treating senile dementia and its preparing process
CN115040612A (en) Composition for regulating hypertension and preparation method thereof
CN113288998A (en) Chinese medicinal formula for stabilizing blood sugar diseases and preparation scheme
CN102631498B (en) Chinese medicinal composition
CN102631492B (en) Chinese medicinal composition for improving immunity and resisting fatigue
CN113144084A (en) Traditional Chinese medicine composition for treating frequent ventricular premature beat and application thereof
CN102600231A (en) Anti-fatigue nutrient and preparation method thereof
CN102631490B (en) Traditional Chinese medicine composition capable of improving immunity and resisting fatigue
CN104800600A (en) Medicine for treating hypertension
CN108671116A (en) Herbal composite and its preparation for treating diabetes and instructions of taking
CN104435685A (en) Medicine for treating xerophthalmia and preparation method thereof
CN108853340A (en) A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof
CN102631506B (en) Traditional Chinese medicine composition capable of improving immunity and resisting fatigue
CN103055133A (en) Traditional Chinese medicine for treating hypertension and hyperlipidemia and preparation method of traditional Chinese medicine
CN103690902B (en) For preventing the Chinese medicine preparation of nasopharyngeal carcinoma radiation side reaction
CN102631487B (en) Traditional Chinese medicine composition capable of improving immunity and resisting fatigue
CN104547103A (en) Traditional Chinese medicinal composition for treating cardiac neurosis and preparation method of preparations thereof
CN105878732A (en) Traditional Chinese medicine for curing diabetes and preparation method thereof
CN104825735A (en) Kidney-tonifying health wine
CN117797106A (en) Pill with effects of dispelling effects of alcohol and protecting liver and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination